Terms: = Germ cell tumor AND ATR, Q13535, 545, ENSG00000175054, MEC1, SCKL, SCKL1, FRP1 AND Treatment
112 results:
1. Distinguishing IDH mutation status in gliomas using FTIR-atr spectra of peripheral blood plasma indicating clear traces of protein amyloid aggregation.
Kino S; Kanamori M; Shimoda Y; Niizuma K; Endo H; Matsuura Y
BMC Cancer; 2024 Feb; 24(1):222. PubMed ID: 38365669
[TBL] [Abstract] [Full Text] [Related]
2. atr inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines.
Lozinski M; Bowden NA; Graves MC; Fay M; Day BW; Stringer BW; Tooney PA
Oncotarget; 2024 Jan; 15():1-18. PubMed ID: 38227740
[TBL] [Abstract] [Full Text] [Related]
3. ALK signaling primes the DNA damage response sensitizing ALK-driven neuroblastoma to therapeutic atr inhibition.
Borenäs M; Umapathy G; Lind DE; Lai WY; Guan J; Johansson J; Jennische E; Schmidt A; Kurhe Y; Gabre JL; Aniszewska A; Strömberg A; Bemark M; Hall MN; Eynden JVD; Hallberg B; Palmer RH
Proc Natl Acad Sci U S A; 2024 Jan; 121(1):e2315242121. PubMed ID: 38154064
[TBL] [Abstract] [Full Text] [Related]
4. Changes in tumor-to-blood ratio as a prognostic marker for progression-free survival and overall survival in neuroendocrine tumor patients undergoing PRRT.
Weber M; Pettersson O; Seifert R; Schaarschmidt BM; Fendler WP; Rischpler C; Lahner H; Herrmann K; Sundin A
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):841-851. PubMed ID: 37947848
[TBL] [Abstract] [Full Text] [Related]
5. DNA damage response inhibitors enhance tumour treating fields (TTFields) potency in glioma stem-like cells.
Vanderlinden A; Jones CG; Myers KN; Rominiyi O; Collis SJ
Br J Cancer; 2023 Nov; 129(11):1829-1840. PubMed ID: 37777579
[TBL] [Abstract] [Full Text] [Related]
6. Analysis of Quinolinequinone Analogs with Promising Cytotoxic Activity against Breast Cancer.
Yilmaz Goler AM; Tarbin Jannuzzi A; Biswas A; Mondal S; Basavanakatti VN; Jayaprakash Venkatesan R; Yıldırım H; Yıldız M; Çelik Onar H; Bayrak N; Jayaprakash V; TuYuN AF
Chem Biodivers; 2023 Sep; 20(9):e202300848. PubMed ID: 37590495
[TBL] [Abstract] [Full Text] [Related]
7. Nivolumab for newly and recurrent glioblastoma multiforme treatment: A systematic review and meta-analysis.
Araujo Moura AW; da Silva Rodrigues S; de Oliveira TF; Lobato BM; Pereira Cerize NN; Léo P
J Oncol Pharm Pract; 2023 Oct; 29(7):1736-1747. PubMed ID: 37503551
[TBL] [Abstract] [Full Text] [Related]
8. Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Pearson ADJ; Federico S; Gatz SA; Ortiz M; Lesa G; Scobie N; Gounaris I; Weiner SL; Weigel B; Unger TJ; Stewart E; Smith M; Slotkin EK; Reaman G; Pappo A; Nysom K; Norga K; McDonough J; Marshall LV; Ludwinski D; Ligas F; Karres D; Kool M; Horner TJ; Henssen A; Heenen D; Hawkins DS; Gore L; Bender JG; Galluzzo S; Fox E; de Rojas T; Davies BR; Chakrabarti J; Carmichael J; Bradford D; Blanc P; Bernardi R; Benchetrit S; Akindele K; Vassal G
Eur J Cancer; 2023 Sep; 190():112950. PubMed ID: 37441939
[TBL] [Abstract] [Full Text] [Related]
9. Chrysin-Induced Regression of Angiogenesis via an Induction of DNA Damage Response and Oxidative Stress in In Vitro and In Vivo Models of Melanoma.
Sassi A; Fredon M; Cotte AK; Fuselier C; Schneider C; Martiny L; Monchaud D; Chekir-Ghedira L; Aires V; Delmas D
Cells; 2023 Jun; 12(12):. PubMed ID: 37371032
[TBL] [Abstract] [Full Text] [Related]
10. Thiol functionalised gold nanoparticles loaded with methotrexate for cancer treatment: From synthesis to in vitro studies on neuroblastoma cell lines.
Salamone TA; Rutigliano L; Pennacchi B; Cerra S; Matassa R; Nottola S; Sciubba F; Battocchio C; Marsotto M; Del Giudice A; Chumakov A; Davydok A; Grigorian S; Canettieri G; Agostinelli E; Fratoddi I
J Colloid Interface Sci; 2023 Nov; 649():264-278. PubMed ID: 37348346
[TBL] [Abstract] [Full Text] [Related]
11. New perspective on DNA response pathway (DDR) in glioblastoma, focus on classic biomarkers and emerging roles of ncRNAs.
Pirlog BO; Ilut S; Pirlog R; Chiroi P; Nutu A; Radutiu DI; Cuc GD; Berindan-Neagoe I; Nabavi SF; Filosa R; Nabavi SM
Expert Rev Mol Med; 2023 May; 25():e18. PubMed ID: 37154101
[TBL] [Abstract] [Full Text] [Related]
12. ATM depletion induces proteasomal degradation of FANCD2 and sensitizes neuroblastoma cells to PARP inhibitors.
Parvin S; Akter J; Takenobu H; Katai Y; Satoh S; Okada R; Haruta M; Mukae K; Wada T; Ohira M; Ando K; Kamijo T
BMC Cancer; 2023 Apr; 23(1):313. PubMed ID: 37020276
[TBL] [Abstract] [Full Text] [Related]
13. ATM inhibition enhances the efficacy of radiation across distinct molecular subgroups of pediatric high-grade glioma.
Xie J; Kuriakose T; Bianski B; Twarog N; Savage E; Xu K; Zhu X; He C; Hansen B; Wang H; High A; Li Y; Rehg JE; Tillman HS; Freeman BB; Rankovic Z; Onar-Thomas A; Fan Y; Wu G; Peng J; Miller S; Baker SJ; Shelat AA; Tinkle CL
Neuro Oncol; 2023 Oct; 25(10):1828-1841. PubMed ID: 36971093
[TBL] [Abstract] [Full Text] [Related]
14. Factors affecting eye conservation and metastasis in posterior uveal melanomas.
Nalcı Baytaroğlu H; Gündüz AK; Mirzayev I; Özalp Ateş FS
Eur J Ophthalmol; 2023 Sep; 33(5):2024-2033. PubMed ID: 36762394
[TBL] [Abstract] [Full Text] [Related]
15. Nano-scaled emulsion and nanogel containing Mentha pulegium essential oil: cytotoxicity on human melanoma cells and effects on apoptosis regulator genes.
Azadi S; Osanloo M; Zarenezhad E; Farjam M; Jalali A; Ghanbariasad A
BMC Complement Med Ther; 2023 Jan; 23(1):6. PubMed ID: 36624422
[TBL] [Abstract] [Full Text] [Related]
16. Critical Appraisal of Paediatric Embryonal Cancers Treated with Image-guided Intensity-modulated Proton Therapy.
Sharma DS; Padanthaiyil NM; Krishnan G; Arjunan M; Reddy AK; Mahammood S; Gayen S; Thiyagarajan R; Gaikwad U; Sudarsan RT; Chilukuri S; Jalali R
Clin Oncol (R Coll Radiol); 2023 Apr; 35(4):227-236. PubMed ID: 36609026
[TBL] [Abstract] [Full Text] [Related]
17. ARPC1B promotes mesenchymal phenotype maintenance and radiotherapy resistance by blocking TRIM21-mediated degradation of IFI16 and HuR in glioma stem cells.
Gao Z; Xu J; Fan Y; Zhang Z; Wang H; Qian M; Zhang P; Deng L; Shen J; Xue H; Zhao R; Zhou T; Guo X; Li G
J Exp Clin Cancer Res; 2022 Nov; 41(1):323. PubMed ID: 36380368
[TBL] [Abstract] [Full Text] [Related]
18. Split-Tendon Medial Transposition of Lateral Rectus for Pediatric Complete Oculomotor Palsy.
Zhang KX; Varma H; Cao Y; Shah VS
J Neuroophthalmol; 2023 Jun; 43(2):254-260. PubMed ID: 36342135
[TBL] [Abstract] [Full Text] [Related]
19. Correlation of Clinicopathological Factors with Brain tumor-Related Epilepsy in Glioma.
Wang Z; Yang W; Wang Y; Aili Y; Wang Z; Wang Q; Jiang S; Zhang G; Zhang J; Li B
Dis Markers; 2022; 2022():4918294. PubMed ID: 36246555
[TBL] [Abstract] [Full Text] [Related]
20. tumor-specific radiosensitizing effect of the ATM inhibitor AZD0156 in melanoma cells with low toxicity to healthy fibroblasts.
Scheper J; Hildebrand LS; Faulhaber EM; Deloch L; Gaipl US; Symank J; Fietkau R; Distel LV; Hecht M; Jost T
Strahlenther Onkol; 2023 Dec; 199(12):1128-1139. PubMed ID: 36229655
[TBL] [Abstract] [Full Text] [Related]
[Next]
